EPZ011989 |
|
Synonyms: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl((1r,4r)-4-((2-methoxyethyl)(methyl)amino)cyclohexyl)amino)-2-methyl-5-(3-morpholinoprop-1-ynyl)benzamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl-[4-[2-methoxyethyl(methyl)amino]cyclohexyl]amino]-2-methyl-5-(3-morpholin-4-ylprop-1-ynyl)benzamide;EPZ-011989, EPZ 011989 | |
Cat. No.: E98000 | CAS No.: 1598383-40-4 |
MDL.: | Formula: C35H51N5O4 |
F.W.604.82 | Purity: 99% |
Storage: | |
  |

Catalog Number: | E98000 | CAS No.: | 1598383-40-4 | |
MDL: | Formula: | C35H51N5O4 | ||
F.W.: | 604.82 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DMSO | Stability: | ||
Storage: | Category: | Reference Standard | ||
Reference: | John E. Campbell et. al., ACS Med. Chem. Lett., 2015, 6 (5), pp 491–495 | |||
Application: | EPZ011989 is a potent, selective orally bioavailable EZH2 inhibitor with Ki < 3 nM for EZH2 wt and EZH2 Y646; 15-fold selectivity over EZH1 and >3000-fold selectivity over other HMTase. |